Related by context. All words. (Click for frequent words.) 79 Complete Response Letter 77 FDA approvable letter 76 Complete Response Letter CRL 74 FDA Approvable Letter 72 FDA Complete Response 71 Approvable Letter 70 Complete Response 68 Silenor NDA 67 approvable letter 67 Intermezzo ® NDA 66 lorcaserin NDA 66 approvable letters 64 Approvable letter 64 Not Approvable 64 Staff Determination Letter 64 Warning Letter 63 BLA filing 62 NASDAQ Hearings Panel 62 Staff Deficiency Letter 62 assigned PDUFA 62 Marketing Authorisation Application 62 novel trazodone formulation 62 DATES Comments 62 supplemental Biologics License Application 62 Act PDUFA date 62 Marketing Authorization Application MAA 61 CIP TRAMADOL ER 61 Biological License Application 61 Biologics License Application 61 Citizen Petition 61 APF# NDA 61 Marketing Authorization Application 61 Orathecin 61 PDUFA date 61 Impax ANDA 61 Submits Response 61 BLA submission 61 Nasdaq Hearings Panel 60 eprodisate KIACTA TM 60 Biologic License Application BLA 60 inspectional observations 60 MyVax R 60 Biologics License Application BLA 60 Premarket Approval PMA 60 Marketing Authorisation Application MAA 60 GRAS notification 60 sNDA submission 59 sBLA 59 Premarket Approval Application 59 nonclinical studies 59 ZEGERID Chewable Tablets 59 L MTP PE 59 Barr ANDA 59 MAA submission 59 Nasdaq Listing Qualification 59 oxymorphone ER 59 Paragraph IV Notice 59 Staff Determination 59 alogliptin NDA 58 Application MAA 58 REMOXY NDA 58 NASDAQ Listing Qualification 58 trading symbol GCKO 58 sNDA 58 Nasdaq CYCC Nasdaq CYCCP 58 DATES Written comments 58 Pre IND 58 PRNewswire FirstCall Genta Incorporated 58 Marketing Approval PMA 58 Application BLA 58 CHMP 58 NYSE Amex PTN 58 Fast Track designations 58 MAGE A3 ASCI 58 Expedited Review 58 CORLUX CORT # 58 testosterone gel LibiGel 58 corticotropin injection 58 ANDA submission 58 Supplemental Biologics License Application 57 markets HP Acthar 57 Marketing Authorization Applications 57 IND Investigational New 57 AMEX IVX LSE IVX.L 57 NYSE Amex HEB 57 Prestara TM 57 CHMP recommendation 57 Investigational Device Exemption 57 naronapride 57 NASDAQ TARG 57 granted Ortec 57 PIX# trial 57 Nabi HB Intravenous 57 severe hypercholesterolemia 57 PMA Supplement 57 Contrave NDA 57 Drug Submission 57 Linjeta TM 57 PROVENGE ® 57 commercialize oritavancin 57 XL# anticancer compounds 57 NASDAQ NPSP 57 k Premarket Notification 57 ATPace TM 57 SWX BSLN 57 SILENOR 57 Saforis 57 NasdaqCM RPRX today 56 Amex PME 56 Marketing Authorisation 56 NDA resubmission 56 IND submission 56 submitted Biologics License 56 k premarket 56 Ophthalmic Drugs Advisory 56 Inc. NASDAQ NEOL 56 novel MetAP 2 56 Emezine 56 subsidiaries visit http:/www.apricusbio.com 56 indiplon capsules 56 LibiGel NDA 56 Dated announcements 56 Completes Patient Enrollment 56 liver resection surgeries 56 corticosteroids immunoglobulins 56 Targanta Therapeutics Corporation 56 Listing Qualifications Staff 56 Nasdaq SPPI 56 PDUFA Date 56 Junovan 56 Deficiency Letter 56 balsalazide tablet 56 telavancin NDA 56 vapreotide acetate 56 Company Prospectus dated 56 sNDAs 56 FOLOTYN ® 56 Files Investigational 56 ULTRASE 56 NASDAQ IPXL today 56 Nasdaq Listings Qualification 56 Pink Sheets TAROF 56 Fibrillex TM 56 Resubmission 56 ruxolitinib 56 elotuzumab 56 Premarket Approval 56 NYSE Amex SNG 56 Nasdaq DVAX 56 orphan designation 56 NEBIDO 56 mesylate tablets 55 New Drug Application 55 Zolpimist 55 NASDAQ AVNR 55 NASDAQ ENZN 55 AMEX ONI 55 Sanctura XR 55 NASDAQ BDSI 55 NASDAQ CPEX 55 OMP designation 55 Valid proxies 55 FDA Accepts 55 Fast Track Status 55 Nasdaq RPRX 55 pulls Darvon painkiller 55 Inc. NASDAQ NBIX 55 oral ridaforolimus 55 supplemental biologics 55 SPARLON 55 Risperidone Oral Solution 55 hypersensitivity allergic reactions 55 eTag assays 55 Prestara 55 Receives Milestone Payment 55 Zenvia ™ 55 TSX SHQ 55 Paragraph IV Certification 55 mesylate tablets approved 55 Biologic License Application 55 Announces Tentative Approval 55 approvability 55 OMAPRO ™ 55 Market Authorization Application 55 Fast Track designation 55 hoFH 55 Dyloject TM 55 Orphan Drug status 55 Oncologic Drugs Advisory 55 targeting refractory relapsing 55 Inc. Nasdaq SEPR 55 CHMP opinion 55 Surfaxin lucinactant 55 tafamidis 55 PMA submission 55 Rhucin R 55 NASDAQ GNTA 55 mifamurtide 55 Keppra ® XR 55 Nasdaq WCRX 55 proprietary Capillary Aerosolization Technology 55 investigational humanized monoclonal antibody 55 Receives Approvable Letter 55 Oracea TM 55 Insmed Incorporated NASDAQ INSM 55 Inc. NASDAQ HITK 55 TSX VENTURE PEF 55 Tezampanel 55 autologous cellular immunotherapy 55 R rilonacept Injection 54 interferon gamma 1b 54 Regeneron Pharma 54 Plicera 54 @ pcusa.org -defiers 54 Anti Infective Drugs 54 Kynapid 54 AIDAC 54 ENZON 54 lucinactant 54 MAXY alpha 54 Kamada AAT 54 refractory chronic lymphocytic 54 Phase Ib study 54 National Coverage Determination 54 alvimopan 54 CIMZIA r 54 http:/www.cortexpharm.com 54 Adentri 54 FACTIVE R gemifloxacin 54 Junovan TM 54 Accelerated Approval 54 Submits Investigational 54 FDA Oncologic Drugs 54 HepaGam B TM 54 Orphan Drug designations 54 LymphoStat B TM 54 resubmission 54 Centralized Procedure 54 Submits IND 54 Final Appraisal Determination 54 RIGScan CR 54 Reexamination Certificate 54 APTIMA HPV assay 54 Romiplostim 54 ISO Vorin TM 54 plc Nasdaq WCRX 54 ENTEREG ® 54 HP Acthar Gel repository 54 prGCD 54 oral prodrug 54 Receives Complete Response 54 Phase IIa clinical trials 54 No Objection Letter 54 Velac 54 MONOVISC 54 Receives Orphan Drug Designation 54 VitiGam 54 Nasdaq OSCI 54 application sNDA 54 Combidex 54 TWYNSTA ® 54 postoperative ileus POI 54 FDA Anti Infective 54 Submits NDA 54 Dr. Gulfo 54 Luveris 54 Product Monograph 54 Panzem R 54 QNEXA 54 Linjeta 54 Receives Fast Track 54 TSX VENTURE RM OTCQX 54 Nasdaq DCTH 54 GTC recombinant form 54 Nasdaq Delisting Notification 54 TAXUS Element Stent System 54 GLP toxicology studies 54 VALSTAR 54 CONBRIZA 54 IIa trial 54 RIGScan ™ 54 LensAR Laser System 54 Xcytrin R 54 Auxilium Pharma 53 NDA submission 53 AnorMED expectation 53 V Everolimus Eluting Coronary 53 ketolide antibiotic 53 Marketing Authorization 53 USFDA approval 53 Natural Resources MinAmb 53 NASDAQ CXSP announced 53 BYDUREON 53 T Pred 53 Nasdaq Listings Qualifications 53 PERSHIMCO RESOURCES INC. 53 TORISEL 53 Nasdaq CYPB 53 GLOBE NEWSWIRE Icagen 53 Civacir 53 Known hypersensitivity 53 NasdaqGM SPPI 53 Inc. NASDAQ BPAX 53 generic Copaxone 53 www.vioquestpharm.com 53 OTCBB LEVP 53 MTVO 53 Exelbine NDA 53 Ravelston Entities 53 Unsolicited Proposal From 53 proprietary transdermal patch 53 ZEGERID Capsules 53 Announces Poster Presentations 53 Genasense ® oblimersen 53 see www.virexx.com 53 Hearings Panel 53 dextromethorphan quinidine 53 AMEX AOM 53 Stavzor 53 Drug Application 53 Regains NASDAQ 53 carcinogenicity studies 53 SILENOR TM 53 Inc. Nasdaq MYL 53 SPIRIVA HandiHaler 53 Inc. OTCBB VODG 53 Orphan Status 53 TSX QLT QLT 53 BioDelivery Sciences 53 Ceflatonin 53 ALLSCHWIL BASEL SWITZERLAND 53 Lenocta TM 53 RANK Ligand inhibitor 53 SPL# Gel vaginal microbicide 53 FACTIVE tablets 53 NasdaqGM NTEC today 53 Initiates Enrollment 53 Marketing Authorizations 53 Receives NASDAQ 53 TSX VENTURE GAP 53 Cellegesic 53 Scientific Advice 53 Master File DMF 53 NYSE AMEX PLX 53 Form #Q filed 53 Nasdaq ENZN 53 virus HCV protease inhibitor 53 highly purified pasteurized 53 GATTEX TM 53 RGRX 53 LSE SHP NASDAQ SHPGY 53 Cimzia TM 53 Inc. NASDAQ OSTE 53 MVLWB 53 Ohr Pharmaceutical Inc. 53 Morphine Sulfate 53 KINDERHOOK NY BUSINESS WIRE 53 Nasdaq VRTX 53 pseudobulbar affect PBA 53 GTC recombinant human 53 TSX VENTURE KTX 53 Amended Notice 53 treat atrial flutter 53 Soliris TM eculizumab 53 targeted molecular radiotherapeutics 53 CINTREDEKIN BESUDOTOX 53 VIAject R 53 TSX RVX 53 Omigard 53 Fortical R 53 Orphan Drug designation 53 authority Gurian Sherman 53 CERVARIX R 53 Listing Qualifications Panel 53 MRL Offers 53 Vilazodone 53 NASDAQ FLML 53 NASDAQ Listing Qualifications 53 BRILINTA 53 #D#C# 53 sitaxsentan sodium 53 Fast Track Designation 53 dacetuzumab collaboration 53 Nasdaq SLXP 53 HSR clearance 53 Aloxi Injection 53 prucalopride 53 Synerx 53 Liprotamase 53 TSX DND 53 vinorelbine emulsion 53 Fludara ® 53 phase IIb trial 53 Offering Memorandum dated 53 alogliptin 53 Amlodipine Besylate Tablets 53 investigational atypical antipsychotic 53 cladribine tablets 53 filed Form #b 53 investigational antiplatelet agent 53 Dacogen injection 53 Listings Qualifications Panel 53 NASDAQ ISTA 52 Friedreich Ataxia FRDA 52 KRYSTEXXA TM pegloticase 52 http:/www.repligen.com 52 PREOS 52 Pivotal Phase III 52 Receives Anticipated 52 tiapamil 52 Myfortic 52 Nascobal Nasal Spray 52 Orapred ODT 52 TSX VENTURE HUI FRANKFURT 52 Augment Injectable 52 Belimumab 52 Rhucin ® 52 NASDAQ IMDC 52 FavId 52 Phase 2a Trial 52 bafetinib demonstrated 52 NASDAQ SHPGY 52 SinuNase ™ 52 PNP inhibitor 52 Initiates Phase II 52 cinacalcet HCl 52 TRISENOX ® 52 Efficacy Results 52 TSX GMX FRANKFURT STUTTGART 52 CIP ISOTRETINOIN 52 depressive episodes associated 52 MTA CTIC announced 52 pentadentate logo R 52 MK #B 52 ARCOXIA 52 http:/www.nabi.com 52 Arzerra ofatumumab 52 vertebral augmentation 52 visit www.regenbio.com 52 ASX CXS 52 LymphoStat B belimumab 52 ANDA containing 52 ZOLINZA 52 ADVEXIN p# therapy 52 b.cektir @ todayszaman.com 52 efalizumab 52 Methylphenidate Transdermal System 52 Valeant unsolicited 52 CryoSeal FS System 52 REVLIMID lenalidomide 52 Silodosin 52 Directors Circular dated 52 Gel repository corticotropin injection 52 Voraxaze 52 Submits Supplemental 52 OMNARIS HFA 52 #QSB 52 Oracea ® 52 Entocort 52 Fishers Lane 52 Approvable 52 PRNewswire FirstCall Camtek Ltd. 52 OTCBB FROI 52 Nasdaq MYL 52 histamine dihydrochloride 52 EGRIFTA ™ 52 AVADO 52 Cetirizine Hydrochloride Syrup 52 please email chris@chfir.com 52 Audited Financials 52 Vernakalant 52 Metformin HCl 52 Soriatane 52 Telavancin 52 Asentar TM 52 Horizant ™ 52 liprotamase 52 SURFAXIN 52 REGENERX BIOPHARMACEUTICALS INC. 52 European Medicines Evaluation 52 rasagiline tablets 52 Inc. Amex ILE 52 www.soligenix.com 52 Sumatriptan Succinate Tablets 52 SEDAR www.SEDAR.com 52 placebo controlled clinical trials 52 IMPAX Laboratories Inc. 52 Uvidem 52 Alair System 52 bazedoxifene 52 Research CBER 52 Oral Calcitonin 52 submitted supplemental Biologics 52 Shareholder Letter 52 BioGlue ® 52 Clinical Trial Application 52 Therapeutic Competitors Companies 52 SPRYCEL ® 52 BEMA TM LA 52 Submits Biologics License Application 52 RECOTHROM R 52 Frova ® 52 Release Capsules 52 Nebido 52 Zolpidem Tartrate Tablets 52 PRAECIS PHARMACEUTICALS INCORPORATED 52 Levoleucovorin 52 PLK1 SNALP 52 Clinical Trials Update 52 Raptiva R 52 Somatuline R Autogel R 52 iloperidone 52 Corrective Action Order 52 Linjeta ™ 52 Nasdaq BDSI 52 BrachySil 52 Entereg R 52 brivaracetam 52 ENRICH trial 52 Oral Suspension 52 Inc. Nasdaq CVTX 52 Rights Offering Circular 52 Form 8K filed 52 VISICOL R 52 OTC ZEGERID 52 Nasdaq ASYT 52 Topher Kessler 52 initiate Phase 1b 52 octreotide implant 52 Company Nasdaq PRGO 52 pralatrexate injection folate analogue 52 orphan medicinal product 52 SCHWARZ PHARMA 52 Zenpep 52 sapropterin dihydrochloride 52 Inc. Nasdaq IDMI 52 Phase 1a clinical 52 Dementia Related Psychosis 52 TRANSDUR Bupivacaine 52 #KSB 52 UPLYSO 52 TSX PLB leading 52 ATPace 52 Ixempra 52 successfully commercialize Iluvien 52 Evoltra ® 52 FIRAZYR 52 NexMed Receives 52 Make Normal Course 51 Granted Orphan Drug 51 PINKSHEETS IDTA CEO 51 opinion@dailycardinal.com 51 PRNewswire FirstCall Cell Genesys 51 Recommendation Statement 51 SHEETS AUAYF FRANKFURT A9N 51 IV acetaminophen 51 Theratechnologies submitted 51 INSPIRE Trial Phase III 51 nasal calcitonin product 51 Cobalt Pharmaceuticals 51 Angiox ® 51 OTC IPXL 51 octreotide acetate 51 SNT MC# 51 Clinical Trial Data 51 gastrointestinal disorders characterized 51 Trobalt 51 Guanilib 51 Gestiva TM 51 Fibrocell Science Inc. 51 Ticagrelor 51 SmPC 51 novel bactericidal 51 eltrombopag 51 peginesatide 51 Somatuline Depot 51 Cerberus ABP Investor 51 Premarket Notification 51 website www.nyandcompany.com 51 Evoltra TM 51 Indevus Pharma 51 PFIZER DISCLOSURE NOTICE 51 Act PDUFA 51 ENLIGHT 51 Exelbine 51 TAXUS Element Paclitaxel Eluting 51 Transcept Pharmaceuticals 51 Orphan Drug Designation 51 Inc. NASDAQ AVNR 51 BEMA Granisetron 51 Ocrelizumab 51 Personalized Immunotherapy 51 Cabilly patent 51 EVLT R procedure 51 Sanvar R 51 Luveniq 51 NYSE Amex RGN 51 Receives Orphan Drug 51 dihydrochloride Tablets 51 Nasdaq CAMT 51 generation purine nucleoside 51 HCV protease inhibitor 51 MelaFind ® 51 FastMarkets Ltd 51 Amlodipine Besylate 51 NDA Submission 51 alglucosidase alfa 51 www.repligen.com 51 Sunesis Pharmaceuticals 51 Sertraline Hydrochloride Tablets 51 Files IND 51 Valortim TM 51 Inc. Nasdaq RDYN 51 Nasdaq Deficiency Notice 51 ZEGERID Powder 51 OTCBB CLRI 51 Indicative Proposal 51 Market Approval PMA 51 Phase IIb Clinical Trial 51 WDEQ 51 Demonstrates Significant 51 Directors Circular 51 JOULFERON 51 Allovectin 7 r 51 Inc. NASDAQ ONTY 51 business@scni.com 51 NASDAQ INGN 51 Drug Applications ANDAs 51 Rotarix ® 51 Sunesis Pharma 51 NASDAQ SLXP 51 Mylan Receives Approval 51 Full Prescribing Information 51 initiate Phase IIb 51 velaglucerase alfa 51 Nasdaq ENCY 51 Octreolin 51 NASDAQ RPRX 51 NASDAQ NOVN 51 Repurchase Notice 51 azficel T 51 carcinogenicity study 51 TSX VENTURE SPQ Spider 51 XL# XL# XL# XL# 51 By JAMAAL ABDUL 51 Sprycel dasatinib 51 miconazole MBT 51 PROMACTA 51 Aeolus Pharmaceuticals Announces 51 Rhucin ® recombinant 51 Axcan Pharma Holding BV 51 MAb therapy 51 NASDAQ ABPI 51 intravenous acetaminophen 51 ELADUR 51 Ltd. Nasdaq CHRT 51 Pegloticase 51 MedWatch website 51 methylnaltrexone 51 non nucleoside inhibitor 51 Pruvel 51 WSE IVX 51 PROGENSA R 51 EFFECTIVE DATE 51 Gets FDA Clearance 51 iloprost Inhalation Solution 51 NASDAQ Delisting Notice 51 Company TSX FNI 51 StaphVAX R 51 Clemens truthfulness 51 DE BEIRA 51 DASISION 51 MOZOBIL 51 Exemption IDE approval 51 inhaled formulation 51 Novel Antibiotic 51 Pivotal Clinical Trial 51 Neupro ® 51 Increlex TM 51 www.thallion.com 51 OsmoPrep 51 Vion Pharmaceuticals 51 lender consents 51 KRYSTEXXA TM 51 Entereg alvimopan 51 NASDAQ Listing 51 INDICATED LOWER 51 VIAject 51 ANTEGREN 51 Nexavar sorafenib 51 ChemGenex Pharmaceuticals Limited 51 PROMUS Element Stent System 51 License Application sBLA 51 Cota Monroy Who 51 Act PDUFA guidelines 51 please visit http:/www.sunesis.com 51 Palatin Technologies Inc. 51 TSX ELD AMEX EGO 51 ATryn R 51 Adenuric R 51 visit http:/www.mannkindcorp.com 51 Adamis Pharmaceuticals Corporation 51 SHP.L 51 Solzira TM 51 IND Application 51 Rocmec Mining inc 51 livingeditor@sltrib.com 51 MZEI 51 TSX GGN OTCBB GYPH 51 IND Filing 51 Vascular Wrap TM 51 Torisel 51 stockholder approvals 51 Nio Metals 51 amended Schedule #D 51 Ereska 51 Ambrisentan 51 vilazodone 51 TELINTRA 51 Surfactant Technology 51 proprietary intravenous formulation 51 Nasdaq NABI 51 Preos 51 NASDAQ EVCI 51 NASDAQ Deficiency Notice 51 Alvesco R 51 aztreonam lysine 51 OLpur TM H2H 51 Apricus Bio 51 remitting Multiple Sclerosis 51 VCRT 51 prokinetic agent 51 Dr. Damaj 51 TSX VENTURE NML 51 Reports Preclinical Data 51 generic Lovenox 51 Milestone Payment From 51 Zensana 51 postherpetic neuralgia PHN 51 Alogliptin 51 CROWFLIGHT MINERALS INC. Crowflight 51 Nasdaq ISTA 51 INAMED 51 Argatroban 51 PDE4 inhibitor 50 eprodisate Fibrillex TM 50 Dissident Proxy Circular 50 TSX VENTURE FWR 50 Biologics License Applications 50 POSIDUR TM 50 Teikoku Pharma USA 50 pancreatic enzyme replacement 50 EGRIFTA 50 GRALISE 50 SUTENT ® 50 Final EIS 50 Paragraph IV 50 PHX# 50 Adventrx 50 formerly LymphoStat B 50 Velaglucerase Alfa 50 oral rivaroxaban 50 Form #c# 50 pralatrexate 50 pediatric exclusivity 50 Vitrasert R 50 Biologics Licensing 50 Nasdaq ICOS 50 Amex PTN 50 biostatistical analysis 50 Nasdaq Notice Regarding 50 orBec R 50 LOCs unless 50 Glybera R 50 Anturol TM 50 Biovitrum AB publ 50 NASDAQ MERX 50 ISTODAX 50 Metabasis stockholders 50 QVAR ® 50 Inc. Nasdaq VVUS 50 Amex KAL 50 NSE SUNPHARMA 50 diabetic neuropathic pain 50 ® decitabine 50 investor@delhaizegroup.com 50 Preliminary Assessment Report 50 Partnering Guide 50 faropenem medoxomil 50 Flutiform ™ 50 www.accentia.net 50 Management Proxy Circular 50 Proxy Statement dated 50 Durezol TM 50 diarrhea predominant irritable 50 Graniz Loan 50 Yaacov Shoham 50 Interim Required Filings 50 willy nilly Toner 50 Company TSX URZ 50 Investigational Device Exemption IDE 50 Humanitarian Device Exemption 50 oral methylnaltrexone 50 APF# 50 MethyPatch 50 courier-journal.com/bozich 50 R sipuleucel T 50 IPLEX 50 Onrigin 50 bifeprunox 50 Loramyc ™ 50 Optical Biopsy System 50 Mg Uk 50 Expanded Indication 50 Product Characteristics 50 Priority Review 50 adalimumab Humira 50 MacroChem Corporation 50 Survivin antagonist 50 editor letters@smdailyjournal.com 50 AnnualReport 50 Nasdaq AVNC 50 OvaRex ® MAb 50 Nasdaq Listing Qualifications 50 COMFORT II 50 BENLYSTA 50 PhotoCure 50 Phenoptin 50 OncoGenex Pharmaceutical 50 pantoprazole sodium 50 Testosterone MDTS ® 50 Sources Sought 50 SEDAR.com 50 Androxal ® 50 midstage clinical 50 Nasdaq Listing Rules 50 sBLA filings 50 Spiriva HandiHaler 50 Facet Biotech stockholders 50 AMEX NVD visit 50 SYCREST 50 Statement dated 50 delisting determination 50 Xenazine ® 50 cutaneous T 50 Rhucin 50 solifenacin succinate 50 Methylnaltrexone 50 NUEDEXTA ™ 50 PrevOnco ™ 50 Nasdaq IPXL 50 severe gastroparesis 50 Mailed entries must 50 TNF blocker 50 Paragraph IV certification 50 submitted Marketing Authorization 50 Treanda bendamustine 50 spokesman Steve Tragash 50 TRANSDUR ® 50 Company NYSE KVa 50 TSX VENTURE DMA 50 DISCLOSURE NOTICE 50 TSX PEZ OTCBB 50 faropenem 50 AVASTIN 50 LPM TM 50 Redemption Notice 50 ORENCIA R 50 lexidronam injection 50 Dendreon Provenge 50 casopitant 50 Proxy Circular 50 Form #b 50 Taglich Brothers Initiates Coverage 50 Onco TCS 50 Targretin capsules 50 Q#IR 50 Shri Jai Prakash 50 Nasdaq Listing Rule 50 NYSE Amex PLX 50 Board DSMB 50 Web Site http:/www.cryolife.com 50 phase IIb clinical 50 Zelrix 50 MVEIRB 50 http:/www.gpc-biotech.com 50 investor.relations @ nationalcity.com 50 Inc. Nasdaq BCRX 50 TSX CTI 50 Momenta Pharmaceuticals Inc 50 vinflunine 50 gastrointestinal disorders ATI 50 Statutory Accounts 50 Unsolicited Proposal 50 GALNS 50 lomitapide 50 Egrifta 50 CUSF application 50 Override Agreement 50 http:/www.urigen.com 50 FDA Clearance 50 Inc. Nasdaq NBIX 50 www.deliverchange.com coachscorner 50 Taro Receives 50 PhosLo 50 laxative therapy 50 NYSE MRX 50 Metformin GR 50 CancerVax Corporation 50 Initiates Clinical Trial 50 Orphan Drug Status 50 PIX# [002] 50 Marketplace Rules 50 Initiates Clinical 50 etanercept Enbrel 50 Perlite Canada inc 50 Drug Submission NDS 50 TSX VENTURE KWG KWG 50 Reloxin R 50 plc LSE SHP 50 analyst Simos Simeonidis 50 Factual statements contained 50 achieve sustained virologic 50 www.talecris.com 50 Phase IIb trials 50 Afatinib 50 Nasdaq Delisting Notice 50 News# editors 50 Clinical Trial Results 50 desvenlafaxine 50 cell lymphoma CTCL 50 CoreValve System 50 Completes Enrollment 50 tramiprosate ALZHEMED TM 50 TSX PWE FRANKFURT 50 Draft EIS 50 Certican 50 Shelf Prospectus dated 50 ADVANCE PD 50 Inc. OTCBB CYGX 50 Aloprim TM allopurinol sodium 50 Genta Incorporated OTCBB GNTA.OB 50 CRMD# 50 Neupro R 50 teduglutide 50 human C1 inhibitor 50 registrational trial 50 Dextofisopam 50 NASDAQ OSIR 50 BioGlue Surgical Adhesive 50 TSX AMB 50 ezogabine 50 Fortical ® 50 Naproxen sodium 50 demonstrated antitumor activity 50 requisite consents 50 Initiates Phase III 50 NASDAQ IMCL 50 rhLF 50 ONTAK 50 REPLAGAL 50 NASDAQ SGLP 50 FDA Advisory Panel 50 Pirfenidone 50 Issues Complete Response 50 Symphony tCGM 50 generic Valtrex 50 Focetria 50 rhThrombin 50 ACUROX ® 50 HepaGam B 50 Exocrine Pancreatic Insufficiency 50 Firdapse ™ amifampridine phosphate 50 MelaFind R 50 Pulmonary Allergy Drugs 50 TASE CAMT 50 Consent Revocation Statement 50 SinuNase TM 50 Tracleer R 50 EvaMist TM 50 RapidBlue TM System 50 Poly ICR 50 Plenaxis R 50 CAMPATH R 50 Scheduling Order 50 Silenor ® doxepin 50 ISENTRESS raltegravir 50 miconazole Lauriad R 50 Liberte TM 50 Listing Application 49 LibiGel ® 49 Phase IIb Trial 49 AVGCF Avion 49 Oracea R 49 REMICADE ® 49 Sumatriptan Succinate 49 BID CANCELLATIONS 49 BEMA ® 49 Drug Administration FDA Oncologic